[go: up one dir, main page]

WO2003047629A3 - Treatment of diseases via the skin - Google Patents

Treatment of diseases via the skin Download PDF

Info

Publication number
WO2003047629A3
WO2003047629A3 PCT/GB2002/005394 GB0205394W WO03047629A3 WO 2003047629 A3 WO2003047629 A3 WO 2003047629A3 GB 0205394 W GB0205394 W GB 0205394W WO 03047629 A3 WO03047629 A3 WO 03047629A3
Authority
WO
WIPO (PCT)
Prior art keywords
individual
skin
treatment
administering
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2002/005394
Other languages
French (fr)
Other versions
WO2003047629A2 (en
Inventor
Rachid Tazi-Ahnini
Simon Ward
Michael Cork
Gorden Duff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Molecular Skincare Ltd
Original Assignee
Molecular Skincare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Skincare Ltd filed Critical Molecular Skincare Ltd
Priority to AU2002365654A priority Critical patent/AU2002365654A1/en
Publication of WO2003047629A2 publication Critical patent/WO2003047629A2/en
Publication of WO2003047629A3 publication Critical patent/WO2003047629A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

A method of delivering a molecule to an individual, the method comprising: (a) providing an agent capable of effecting the degradation of a component of the epidermal barrier of the individual; (b) administering the agent to the individual; and (c) administering the molecule to the individual. Specifically described is the use of proteolysis, and other degradative processes for the reduction of epidermal barrier function, to regulate the passage of agents through the stratum corneum and into the body of an individual. A path comprising one or both agents provides a particularly advantageous way of putting the invention into practice.
PCT/GB2002/005394 2001-11-29 2002-11-29 Treatment of diseases via the skin Ceased WO2003047629A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002365654A AU2002365654A1 (en) 2001-11-29 2002-11-29 Treatment of diseases via the skin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0128629.3 2001-11-29
GB0128629A GB0128629D0 (en) 2001-11-29 2001-11-29 Method

Publications (2)

Publication Number Publication Date
WO2003047629A2 WO2003047629A2 (en) 2003-06-12
WO2003047629A3 true WO2003047629A3 (en) 2003-08-28

Family

ID=9926699

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/005394 Ceased WO2003047629A2 (en) 2001-11-29 2002-11-29 Treatment of diseases via the skin

Country Status (3)

Country Link
AU (1) AU2002365654A1 (en)
GB (1) GB0128629D0 (en)
WO (1) WO2003047629A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015144183A1 (en) * 2014-03-26 2015-10-01 University Of Copenhagen Treatment of contact dermatitis

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2556218A1 (en) * 1983-12-12 1985-06-14 Gerard Alain Pharmaceutical product for local application consisting of the combination of a medicinal active ingredient and an enzymatic agent
WO1990009809A1 (en) * 1989-02-23 1990-09-07 University Of Utah Percutaneous drug delivery system
JPH0344310A (en) * 1989-07-10 1991-02-26 Mareyoshi Sawaguchi Cosmetic containing zizania latifolia o.stapf and neighbors thereof
WO1995000651A1 (en) * 1993-06-18 1995-01-05 Astra Aktiebolag Recombinant stratum corneum chymotryptic enzyme (scce)
WO2001034111A1 (en) * 1999-11-08 2001-05-17 The Procter & Gamble Company Cosmetic compositions
WO2001087255A1 (en) * 2000-05-16 2001-11-22 Pacific Corporation External application for enhancing the skin permeability of the active components therein

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2556218A1 (en) * 1983-12-12 1985-06-14 Gerard Alain Pharmaceutical product for local application consisting of the combination of a medicinal active ingredient and an enzymatic agent
WO1990009809A1 (en) * 1989-02-23 1990-09-07 University Of Utah Percutaneous drug delivery system
JPH0344310A (en) * 1989-07-10 1991-02-26 Mareyoshi Sawaguchi Cosmetic containing zizania latifolia o.stapf and neighbors thereof
WO1995000651A1 (en) * 1993-06-18 1995-01-05 Astra Aktiebolag Recombinant stratum corneum chymotryptic enzyme (scce)
WO2001034111A1 (en) * 1999-11-08 2001-05-17 The Procter & Gamble Company Cosmetic compositions
WO2001087255A1 (en) * 2000-05-16 2001-11-22 Pacific Corporation External application for enhancing the skin permeability of the active components therein

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 015, no. 181 (C - 0830) 9 May 1991 (1991-05-09) *

Also Published As

Publication number Publication date
AU2002365654A1 (en) 2003-06-17
AU2002365654A8 (en) 2003-06-17
GB0128629D0 (en) 2002-01-23
WO2003047629A2 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
WO2004028570A3 (en) A method for treating severe tinnitus
WO2000038626A3 (en) Substrate composition and method of use for sequestration of skin irritants
WO2005000161A3 (en) Methods and devices for occluding body lumens and/or for delivering therapeutic agents
WO2002056912A3 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
WO2002100390A3 (en) Improved method of treating the syndrome of coronary heart disease risk factors in humans
NO20034684D0 (en) Device for administering funds through the stratum corcum
WO2007089454A3 (en) Methods for enhancing skin treatments
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
WO2003032815A3 (en) Medical device for delivering patches
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
IL166070A0 (en) Hot-melt tts for administering rotigotine
WO2002076472A3 (en) Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
WO2003084611A8 (en) Depsipeptide for therapy of kidney cancer
WO2004046196A3 (en) Compositions and methods for treating bacterial infections with protein-dalbavancin complexes
WO2003062273A3 (en) Modulator of the notch signalling pathway and use thereof in medical treatment
WO2004098568A3 (en) Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
WO2004110151A8 (en) Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
WO2003011327A3 (en) Secretin for the treatment of asthma
WO2002060410A3 (en) Methods for sustained release local delivery of drugs for ablation of unwanted tissue
SE0102147D0 (en) New methods
DE60119976D1 (en) Thixotropes nasenspray
WO1994017792A3 (en) Compositions and methods for transdermal drug delivery
WO2007047157A8 (en) Surgical device and method for performing combination revascularization and therapeutic substance delivery to tissue
WO2003059250A3 (en) Compositions and methods for treating female sexual arousal disorder using hydrophobic-calcitonin gene related peptide
WO2004007676A3 (en) Combination therapy for the treatment of neoplasms

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP